Article
PDE5A Polymorphisms Influence on Sildenafil Treatment Success
25 May 2016
Abstract excerpt
INTRODUCTION: Diabetes and cardiovascular disease are risk factors for erectile dysfunction (ED). Selective inhibitors of the type 5 phosphodiesterase are the first option for treating ED. However, it is unknown why there are patients with low response to this treatment. Polymorphisms in the PDE5A gene may influence the response to PDE5 inhibitors treatment. AIM: The aim of this study is to analyze the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
